AI
ELV icon

Axecap Investments’s Elevance Health ELV Stock Holding History

Axecap Investments’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$701K Hold
2,396
– – 0.48% 43
2025
Q4 		$840K Sell
2,396
-29
-1% -$9.8K 0.52% 52
2025
Q3 		$784K Sell
2,425
-100
-4% -$31.1K 0.48% 63
2025
Q2 		$982K Sell
2,525
-75
-3% -$30.2K 0.64% 48
2025
Q1 		$1.13M Buy
+2,600
New +$1.04M 0.96% 35

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Axecap Investments's ELV Position: Q1 2026 in Review

Axecap Investments held its Elevance Health (ELV) position steady in Q1 2026 at 2,396 shares worth $701K. The position accounts for 0.48% of the portfolio, ranked #43.

Axecap Investments first reported a position in ELV in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.13M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Axecap Investments held 2,396 shares of Elevance Health worth $701K as of Q1 2026.
  • Axecap Investments left its Elevance Health share count unchanged in Q1 2026.
  • Elevance Health made up 0.48% of Axecap Investments's portfolio in Q1 2026, its #43 holding.
  • Axecap Investments first reported a position in Elevance Health in Q1 2025 and has held it in 5 quarters since.
  • Axecap Investments's Elevance Health position peaked at $1.13M in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Axecap Investments's 13F filing for Q1 2026, filed 20 Apr 2026.